Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.

Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.

http://www.wikidata.org/entity/Q34099937

about

Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives Mechanisms of ectopic calcification: implications for diabetic vasculopathy The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes.Diabetes and cardiovascular disease: let's push forward with translational research A mini-network balance model for evaluating the progression of cardiovascular complications in Goto-Kakizaki rats Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.Hyperglycemia: a bad signature on the vascular system.BLT2 expression improves skin integrity and protects from alterations caused by hyperglycemia in type 2 diabetes.

P2860

Q26778659-FB1CA9F7-A30F-4C97-99CF-38E57FBDB035 Q26778664-43711E94-059B-448B-9C51-93E6D63C5E5D Q35229122-69EE5FD2-B231-47AB-B33D-0A71909476BE Q36174447-E9D401A3-44AB-4141-892A-878BCAFC1E3E Q37688755-E59028ED-5B43-4D6D-BEE8-677FBB320931 Q38524836-73BCE2CC-34D0-4EE8-9307-5EC91D2063DA Q40349239-23B1A766-D222-4379-8164-E66B12C27547 Q42292389-38156A70-4D68-4DB8-B58B-ABCE18BA12E2

P2860

Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.

http://www.wikidata.org/entity/Q34099937

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@ast

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@en

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@nl

type

label

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@ast

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@en

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@nl

prefLabel

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@ast

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@en

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes.

@nl

P1433

Q34099937-8CCCD8C1-4D17-4FA2-990A-9E6D18C178C4

P1476

Q34099937-A5C8A399-CE1A-4A70-83A9-86D0DFB6FC7A

P2093

Q34099937-2FCBD7C1-D54D-426D-ABEF-2B113CD2ACA5

Q34099937-CEBFE493-7597-4752-8033-E3B31C8CD787

P2860

Q34099937-02709532-5001-4748-B3A2-E5D5951A4CD4

Q34099937-03C0BB0C-E586-4517-BAE4-1EFF4AF348C9

Q34099937-05CF99A1-B1D4-437F-973C-BA9F86854D33

Q34099937-0854FD4B-150F-4CC3-BC62-6E9F28674B75

Q34099937-0D0770FF-CAF6-4A35-8B3F-E0DA99DF0831

Q34099937-125E6F5D-F932-4151-AA7B-460C6E82534F

Q34099937-1CAFE55F-3738-48BE-987D-AFD3AF361DF2

Q34099937-2037A80F-DFF3-4C98-B839-477AFBF30C02

Q34099937-222A6D10-497C-45F9-9E3B-4F274D8E72DD

Q34099937-273FB613-7814-4B1D-BAAC-46723C1E74A0

P304

Q34099937-FB918FB4-412D-4B32-9971-7ABC368BBB45

P31

Q34099937-E3B8E03C-6F14-40F1-B38E-B67E04D8323D

P356

Q34099937-28A30E85-3E78-4834-836C-A19AE4A28465

P433

Q34099937-3E9E27AD-B1F5-4179-B34B-D6B981259E2C

P478

Q34099937-419E9447-3881-4B8D-A9EB-87FCBD9777CB

P50

Q34099937-5D746F5E-55A7-40D9-99A1-CAA523A18D90

P577

Q34099937-0B934499-FE5F-4F9A-991F-C0EC5AA6335F

P5875

Q34099937-0FEBB2AD-EA4A-4173-82BE-C45CF89A0DF3

P698

Q34099937-E66C6B8B-CDD1-4822-9C29-F5CC06EDA91E

P921

Q34099937-8C5ED070-8A42-4CEF-9A91-7145678C1A12

Q34099937-AA26AB91-0145-44F2-B070-168F92AC37B3

Q34099937-AFEF3058-AF08-4D4F-B510-38F4FECB09F3

P932

Q34099937-39F06E72-B2DE-4048-A43D-F527380C1BEA

P356

J.ISSN.2223-3652.2014.08.02

P1433

Cardiovascular diagnosis and therapy

P1476

Molecular mechanisms of vascul ...... biomarkers in type 2 diabetes

@en

P2093

Francesco Paneni

http://www.w3.org/2001/XMLSchema#string

Sarah Costantino

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Prevention of overweight/obesity as a strategy to optimize cardiovascular health

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

Simple non-invasive assessment of advanced glycation endproduct accumulation

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

The p66shc adaptor protein controls oxidative stress response and life span in mammals

Oxidative stress and diabetic complications

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

P304

324-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2223-3652.2014.08.02

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Cosentino

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266573596

http://www.w3.org/2001/XMLSchema#string

P698

25276618

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

type-2 diabetes

P932

4147093

http://www.w3.org/2001/XMLSchema#string